HemoCleanse, Inc. spun out of Ash Medical Systems which had been active in SBIR from the earliest days. grounded inteh work of two men of very different background and aras of expertise - Robert B. Truitt MSE, MBA and Stephen R. Ash MD, FACP HemoCleanse focused on application of sorbents to dialysis therapy. Sorbent regeneration of dialysate allowed creation of dialysis therapies that could remove various toxins specifically, minimize the need for water, and allow machines to be easily implemented in the home and other locations outside of the classic in-center dialysis unit. A number of successful products resulted: BioLogic-HD⢠Sorbent Dialysis Machine (FDA approved for treatment of kidney failure in 1986) BioLogic-DT⢠âLiver Dialysisâ Machine (FDA approved for treatment of hepatic coma in 1996) Allient⢠Dialysis Machine (FDA approved for treatment of kidney failure in 2006) Other products ahve followed, many brought to use condition by an active program of new company formation and corporate s
